Stay updated with breaking news from Avisa Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global Clostridium Diagnostics Market is anticipated to grow at a CAGR of 12.2% from 2022 to 2032, from US$ 2.5 billion to US$ 7.8 billion. The market demonstrated a CAGR of 13.6% from 2015 to 2021. The increasing incidence of clostridium-related illnesses and the expansion of public awareness campaigns about th...
The global clostridium diagnostics market is projected to secure US$ 7.8 Billion by 2032 while recording a CAGR of 12.2% during the forecast period. The growth of the market can be attributed to the growing prevalence of clostridium-related diseases and the growing awareness campaigns launched by various authorities...
/PRNewswire/ -- The global clostridium diagnostics market is projected to secure US$ 7.8 Billion by 2032 while recording a CAGR of 12.2% during the forecast...
.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... Justin Crowe, founder and CEO of Parting Stone in Santa Fe, pictured in 2019. The company take human and pet remains and turns them into solidified remains. (Eddie Moore/Albuquerque Journal) ALBUQUERQUE, N.M. — Santa Fe-based Parting Stone’s novel technology to turn cremated ashes into beautiful, solidified remains is rapidly gaining ground in the “deathcare” industry. The company, which la...
Share: NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N. M., May 04, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (formerly, FogChain Corp.) (the "Company") is pleased to announce the closing of its previously announced reverse takeover transaction (the "Transaction") with Avisa Pharma Inc. ("Avisa"). In accordance with the merger agreement and plan of reorganization dated February 1, 2021 (the "Merger Agreement"), which superseded and replaced the previously announced Letter of Intent dated January 12, 2021, the Transaction w...